Thus, we focused on the importance of mutations in GTF2I in the development of type B thymomas using targeted sequencing coupled with techniques in molecular barcoding: more sensitive and specific assays than the whole-exome sequencing approach used in previous studies [10,11]. The gene discussed is GTF2I; the disease is thymoma.